Heart Test Laboratories Inc. Common Stock (HSCS) — Strategic Asset Allocation Index
Heart Test Laboratories Inc. Common Stock (HSCS) has a Strategic Asset Allocation Index of 256.2% as of April 2023. Strategic assets (PP&E of $590.65K plus long-term investments of $-) total $590.65K, measured against net assets of $230.56K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check HSCS tangible net assets ratio to evaluate the tangible quality of the company's equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Heart Test Laboratories Inc. Common Stock Strategic Asset Allocation Index (2020–2023)
This chart shows how Heart Test Laboratories Inc. Common Stock's Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2023. As of April 2023, the index stands at 256.2%, representing strategic assets of $590.65K against net assets of $230.56K USD.
Annual Strategic Asset Allocation Index for Heart Test Laboratories Inc. Common Stock (2020–2023)
The table below presents the year-by-year Strategic Asset Allocation Index for Heart Test Laboratories Inc. Common Stock from 2020 to 2023, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Heart Test Laboratories Inc. Common Stoc stock valuation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2023 | 256.2% | $590.65K | $590.65K | $- | $230.56K | ▲ +123.7 pp |
| 2020 | 132.5% | $418.05K | $418.05K | $- | $315.55K | — |